Brief: IDEAYA Biosciences Announces Clinical Collaboration With Roche In Mtap-Deleted Ras-Mutant Pancreatic Cancer
BRIEF-IDEAYA Biosciences Announces Clinical Collaboration With Roche In Mtap-Deleted Ras-Mutant Pancreatic Cancer June 3 (Reuters) - IDEAYA Biosciences Inc IDYA.O:
IDEAYA BIOSCIENCES ANNOUNCES CLINICAL COLLABORATION WITH ROCHE IN MTAP-DELETED RAS-MUTANT PANCREATIC CANCER
IDEAYA BIOSCIENCES - TO SPONSOR CLINICAL TRIAL WITH JOINT GOVERNANCE WITH ROCHE
IDEAYA BIOSCIENCES - TO INITIATE PHASE 1 COMBINATION COHORTS IN PDAC AND NSCLC
IDEAYA BIOSCIENCES - CO AND ROCHE RETAIN ALL COMMERCIAL RIGHTS TO THEIR RESPECTIVE COMPOUNDS
Source text: ID:nPn5g2pwda
Further company coverage: IDYA.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Roche Holding AG
See all newsTable: Swiss trade surplus at CHF 6.11 bln in May
Brief: Roche - FDA Accepts Supplemental Biologics License Application For Lunsumio And Polivy Combination
Swiss stocks - Factors to watch on June 18
FDA approves first generic version of Roche's flu drug
Brief: FDA Approves First Single-Dose Generic Treatment For Influenza